News
- 2024.11.20
- SymBio Presents Research Results Showing Potential Use of Intravenous Brincidofovir in Combination with Immune Checkpoint Inhibitors as a Therapy for Malignant Lymphoma at the 66th the American Society of Hematology Annual Meeting
- 2024.11.05
- Notice of Appointment of Executive Vice President, Corporate Officer and Global CMO
- 2024.10.31
- Summary of Consolidated Financial Statements for the First Nine Months of Fiscal Year Ending December 31, 2024 [Japanese GAAP]
- 2024.10.23
- SymBio presents data from Phase IIa clinical trial showing clinical efficacy of IV BCV in treating symptoms of adenovirus infection
- 2024.09.30
- SymBio Reaches Settlement Agreement in Patent Infringement Litigation Related to TREAKISYM
Selection News
- 2024.09.18
- Key person interview: Updated the Page
- 2024.08.14
- 中間決算説明会スクリプト（2024年12月期）(Japanese only)
- 2024.08.13
- Article on 2024 1H Earnings Call Featured in Nikkei Biotech Online (Japanese only)
Source: Nikkei Biotech ONLINE, 2024.08.07
Although Nikkei BP grants permission to use the articles, the content of the articles does not constitute a recommendation to purchase/invest in a specific company/organization or product/service.
Unauthorized reproduction, duplication, or electronic storage of the articles/photos/charts, etc. is prohibited.
- 2024.08.08
- 2024年12月期中間決算説明会の動画を掲載しました。(Japanese only)
- 2024.08.05
- 中間決算説明会資料（2024年12月期）(Japanese only)
- 2024.05.13
- 株主通信「SymBio VISION vol.25」(Japanese only)
- 2024.03.26
- 「動画で観るシンバイオ製薬」を更新しました。(Japanese only)
- 2024.03.26
- 第19期定時株主総会の動画を掲載しました。(Japanese only)
- 2024.02.20
- Article on 2023 Earnings Call Featured in Nikkei Biotech Online (Japanese only)
Source: Nikkei Biotech ONLINE, 2024.02.15
Although Nikkei BP grants permission to use the articles, the content of the articles does not constitute a recommendation to purchase/invest in a specific company/organization or product/service.
Unauthorized reproduction, duplication, or electronic storage of the articles/photos/charts, etc. is prohibited.
- 2024.02.14
- 決算説明会資料（2023年12月期）(Japanese only)
- 2023.11.17
- Notice of Relocation of Head Office